Artelo Biosciences (ARTL) Share-based Compensation Growth (1y) (2018 - 2025)
Artelo Biosciences (ARTL) Share-based Compensation Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 71.86% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -3.46% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -7.69% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -8.89% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -22.43% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 11.71% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -4.01% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | 83.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.08% |
| Sep 30, 2025 | 106.70% |
| Jun 30, 2025 | -23.08% |
| Mar 31, 2025 | -9.86% |
| Dec 31, 2024 | -8.22% |
| Sep 30, 2024 | -5.86% |
| Jun 30, 2024 | -13.33% |
| Mar 31, 2024 | -39.83% |
| Dec 31, 2023 | -63.98% |
| Sep 30, 2023 | -63.43% |
| Jun 30, 2023 | -63.65% |
| Mar 31, 2023 | -43.27% |
| Nov 30, 2021 | 1,019.61% |
| Feb 28, 2021 | 224.31% |
| Nov 30, 2020 | -69.65% |
| Aug 31, 2020 | -100.55% |
| May 31, 2020 | -81.90% |
| Feb 29, 2020 | 149.14% |
| Nov 30, 2019 | 309.29% |
| Aug 31, 2019 | 42,475.36% |